| Selective depletion of metastatic stem cells as therapy for human colorectal cancer MV Céspedes, U Unzueta, A Aviñó, A Gallardo, P Álamo, R Sala, ... EMBO molecular medicine 10 (10), e8772, 2018 | 69 | 2018 |
| Self-assembling toxin-based nanoparticles as self-delivered antitumoral drugs L Sánchez-García, N Serna, P Álamo, R Sala, MV Céspedes, M Roldan, ... Journal of controlled release 274, 81-92, 2018 | 62 | 2018 |
| Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach U Unzueta, MV Cespedes, R Sala, P Alamo, A Sánchez-Chardi, ... Journal of controlled release 279, 29-39, 2018 | 43 | 2018 |
| Cancer-specific uptake of a liganded protein nanocarrier targeting aggressive CXCR4+ colorectal cancer models MV Céspedes, U Unzueta, P Álamo, A Gallardo, R Sala, I Casanova, ... Nanomedicine: Nanotechnology, Biology and Medicine 12 (7), 1987-1996, 2016 | 43 | 2016 |
| Engineering secretory amyloids for remote and highly selective destruction of metastatic foci MV Céspedes, O Cano‐Garrido, P Álamo, R Sala, A Gallardo, N Serna, ... Advanced materials 32 (7), 1907348, 2020 | 40 | 2020 |
| Peptide‐Based Nanostructured Materials with Intrinsic Proapoptotic Activities in CXCR4+ Solid Tumors N Serna, MV Céspedes, L Sánchez‐García, U Unzueta, R Sala, ... Advanced Functional Materials 27 (32), 1700919, 2017 | 39 | 2017 |
| GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases R Sala, E Rioja-Blanco, N Serna, L Sánchez-García, P Álamo, ... Drug delivery 29 (1), 1384-1397, 2022 | 18 | 2022 |
| A refined cocktailing of pro-apoptotic nanoparticles boosts anti-tumor activity L Sánchez-García, R Sala, N Serna, P Álamo, E Parladé, ... Acta biomaterialia 113, 584-596, 2020 | 17 | 2020 |
| Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4+ colorectal cancer R Sala, L Sánchez-García, N Serna, MV Céspedes, I Casanova, ... Acta Biomaterialia 99, 426-432, 2019 | 13 | 2019 |
| Nanostructure Empowers Active Tumor Targeting in Ligand‐Based Molecular Delivery H López‐Laguna, R Sala, JM Sanchez, P Álamo, U Unzueta, ... Particle & Particle Systems Characterization 36 (11), 1900304, 2019 | 12 | 2019 |
| Surfaceome profiling of cell lines and patient-derived xenografts confirm FGFR4, NCAM1, CD276, and highlight AGRL2, JAM3, and L1CAM as surface targets for Rhabdomyosarcoma A Timpanaro, C Piccand, AC Uldry, PK Bode, D Dzhumashev, R Sala, ... International journal of molecular sciences 24 (3), 2601, 2023 | 6 | 2023 |
| HTS discovery of PARP1-HPF1 complex inhibitors in cancer T Kellett, R Noor, Q Zhou, H Esquer, R Sala, P Stojanovic, J Rudolph, ... SLAS Discovery 28 (8), 394-401, 2023 | 2 | 2023 |
| In vivo biodistribution of protein nanoparticles for CXCR4 (+) cell-specific targeting in a metastatic colorectal cancer model P Alamo, U Unzueta, C Cabrera, A Gallardo, R Sala, E Medina, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 494-494, 2017 | | 2017 |
| Generation of CXCR4 (+) pancreatic cancer models for the study of tumor dissemination and evaluation of efficacy of antitumor drugs P Alamo, S Carmona, C Cabrera, N de la Fuente, J Szafranska, V Artigas, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 494-494, 2017 | | 2017 |
| CXCR4 overexpressing endometrioid endometrial cancer models for the study of tumor cell dissemination and therapy E Medina-Gutierrez, A Gallardo, R Sala, P Alamo, U Unzueta, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 513-513, 2017 | | 2017 |
| Development of highly metastatic, CXCR4-overexpressing, colorectal cancer models R Sala, A Gallardo, U Unzueta, P Alamo, C Cabrera, E Medina, ... CLINICAL & EXPERIMENTAL METASTASIS 34 (8), 519-519, 2017 | | 2017 |
